Insurance Coverage Guide
Is Tezepelumab Covered by Insurance?
Tezepelumab is a high-cost medication. Prior authorization is typically required, and many plans restrict coverage. Manufacturer patient assistance programs may be available.
Tezepelumab Coverage by Insurance Type
Medicare Part D
May require prior auth; gap coverage applies
Medicaid
Generally covered; state-specific formularies
Employer Insurance
Prior auth usually required; step therapy common
ACA Marketplace
Generally covered; tier placement affects copay
No Insurance
Cash pay from $2788 on Script Unlock — no formulary restrictions
When Cash Pay Beats Insurance for Tezepelumab
- Cash price ($2788) may be lower than your insurance copay — especially for generics
- No prior authorization required for cash pay
- Works at any pharmacy — not limited to your plan network
- No formulary restrictions — get the exact formulation prescribed
- Your data is not shared with insurance companies
from $2788cash price on Script Unlock
FAQs — Tezepelumab Insurance Coverage
Is Tezepelumab covered by insurance?
Tezepelumab is a high-cost medication. Prior authorization is typically required, and many plans restrict coverage. Manufacturer patient assistance programs may be available. If your insurance doesn't cover Tezepelumab or the copay is high, Script Unlock cash prices from $2788 may be your best option.
What if my insurance won't cover Tezepelumab?
If your insurance denies coverage for Tezepelumab, you have several options: (1) appeal the denial, (2) ask your doctor for a formulary alternative, (3) pay the cash price — from $2788 on Script Unlock, which may be less than your copay, (4) check manufacturer patient assistance programs.
Is it ever cheaper to pay cash for Tezepelumab than use insurance?
Yes — for many medications, the cash price is actually lower than the insurance copay. This is especially common for generic drugs and before you've met your deductible. Tezepelumab cash prices start from $2788 on Script Unlock — compare to your plan's cost before filling.